rs116236042

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001009944.3(PKD1):​c.11961C>T​(p.Ala3987Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0034 in 1,582,776 control chromosomes in the GnomAD database, including 172 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 83 hom., cov: 34)
Exomes 𝑓: 0.0019 ( 89 hom. )

Consequence

PKD1
NM_001009944.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.569

Publications

1 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • polycystic kidney disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Caroli disease
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 16-2090926-G-A is Benign according to our data. Variant chr16-2090926-G-A is described in ClinVar as Benign. ClinVar VariationId is 256911.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.569 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0587 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.11961C>T p.Ala3987Ala synonymous_variant Exon 43 of 46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.11961C>T p.Ala3987Ala synonymous_variant Exon 43 of 46 1 NM_001009944.3 ENSP00000262304.4 P98161-1

Frequencies

GnomAD3 genomes
AF:
0.0176
AC:
2683
AN:
152192
Hom.:
82
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0606
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00752
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000413
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.0177
GnomAD2 exomes
AF:
0.00460
AC:
870
AN:
189300
AF XY:
0.00342
show subpopulations
Gnomad AFR exome
AF:
0.0686
Gnomad AMR exome
AF:
0.00306
Gnomad ASJ exome
AF:
0.00101
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000135
Gnomad OTH exome
AF:
0.000996
GnomAD4 exome
AF:
0.00188
AC:
2688
AN:
1430466
Hom.:
89
Cov.:
34
AF XY:
0.00159
AC XY:
1131
AN XY:
710778
show subpopulations
African (AFR)
AF:
0.0668
AC:
2213
AN:
33122
American (AMR)
AF:
0.00335
AC:
140
AN:
41806
Ashkenazi Jewish (ASJ)
AF:
0.000895
AC:
23
AN:
25688
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38828
South Asian (SAS)
AF:
0.0000711
AC:
6
AN:
84374
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38134
Middle Eastern (MID)
AF:
0.00226
AC:
13
AN:
5742
European-Non Finnish (NFE)
AF:
0.0000535
AC:
59
AN:
1103232
Other (OTH)
AF:
0.00393
AC:
234
AN:
59540
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
155
310
464
619
774
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0177
AC:
2694
AN:
152310
Hom.:
83
Cov.:
34
AF XY:
0.0170
AC XY:
1268
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0607
AC:
2521
AN:
41564
American (AMR)
AF:
0.00751
AC:
115
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68018
Other (OTH)
AF:
0.0175
AC:
37
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
136
272
409
545
681
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00899
Hom.:
7
Bravo
AF:
0.0211
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 25, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease, adult type Benign:2
May 11, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 02, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jan 14, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The PKD1 p.Ala3987Ala variant was identified in 2 of 90 proband chromosomes (frequency: 0.22) from individuals or families with ADPKD (Rossetti 2002). This variant was identified in the 1000 Genomes Project in 113 of 5000 chromosomes (frequency: 0.0226), NHLBI GO Exome Sequencing Project in 3 of 8366 European American alleles (frequency: 0.000358594), and 195 of 4250 African American alleles (frequency: 0.045882353), Exome Aggregation Consortium database (August 8, 2016) in 378 (7 homozygous) of 47294 chromosomes (frequency: 0.007993) in the following populations: African in 353 of 3340 chromosomes (frequency: 0.1057) Latino in 19 of 3822 chromosomes (frequency: 0.004971) European (Non-Finnish) in 4 of 23962 chromosomes (frequency: 0.0001669) South Asian in 1 of 10920 chromosomes (frequency: 0.00009158) and Other in 1 of 344 chromosomes (frequency: 00.002907), but was not seen in East Asian and European (Finnish) populations, increasing the likelihood that this may be a low frequency benign variant in certain populations of origin. In addition we cannot be certain that data from control databases is specific to PKD1 and not from one of the six PKD1 pseudogenes. The variant was also identified in dbSNP (ID: rs116236042) as “With Benign allele”, ClinVar and Clinvitae (benign, by Prevention Genetics), ADPKD Mutation Database (Likely neutral). The p.Ala3987Ala variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information, this variant meets our laboratory criteria to be classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
6.7
DANN
Benign
0.87
PhyloP100
0.57
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116236042; hg19: chr16-2140927; API